Anne Mai Wassermann
Anne Mai Wassermann
Computational Molecular Design, Bayer
Verified email at bayer.com
Title
Cited by
Cited by
Year
Activity landscape representations for structure− activity relationship analysis
AM Wassermann, M Wawer, J Bajorath
Journal of medicinal chemistry 53 (23), 8209-8223, 2010
1522010
Dark chemical matter as a promising starting point for drug lead discovery
AM Wassermann, E Lounkine, D Hoepfner, G Le Goff, FJ King, C Studer, ...
Nature chemical biology 11 (12), 958, 2015
832015
SARANEA: a freely available program to mine structure− activity and structure− selectivity relationship information in compound data sets
E Lounkine, M Wawer, AM Wassermann, J Bajorath
Journal of chemical information and modeling 50 (1), 68-78, 2010
832010
Ligand prediction for orphan targets using support vector machines and various target-ligand kernels is dominated by nearest neighbor effects
AM Wassermann, H Geppert, J Bajorath
Journal of chemical information and modeling 49 (10), 2155-2167, 2009
712009
Data structures and computational tools for the extraction of SAR information from large compound sets
M Wawer, E Lounkine, AM Wassermann, J Bajorath
Drug Discovery Today 15 (15-16), 630-639, 2010
632010
Chemical substitutions that introduce activity cliffs across different compound classes and biological targets
AM Wassermann, J Bajorath
Journal of chemical information and modeling 50 (7), 1248-1256, 2010
612010
Searching for target-selective compounds using different combinations of multiclass support vector machine ranking methods, kernel functions, and fingerprint descriptors
AM Wassermann, H Geppert, J Bajorath
Journal of chemical information and modeling 49 (3), 582-592, 2009
562009
Biodiversity of small molecules–a new perspective in screening set selection
PM Petrone, AM Wassermann, E Lounkine, P Kutchukian, B Simms, ...
Drug discovery today 18 (13-14), 674-680, 2013
522013
BindingDB and ChEMBL: online compound databases for drug discovery
AM Wassermann, J Bajorath
Expert opinion on drug discovery 6 (7), 683-687, 2011
522011
SAR matrices: automated extraction of information-rich SAR tables from large compound data sets
AM Wassermann, P Haebel, N Weskamp, J Bajorath
Journal of chemical information and modeling 52 (7), 1769-1776, 2012
492012
Design of multitarget activity landscapes that capture hierarchical activity cliff distributions
D Dimova, M Wawer, AM Wassermann, J Bajorath
Journal of chemical information and modeling 51 (2), 258-266, 2011
492011
Entourage: Visualizing relationships between biological pathways using contextual subsets
A Lex, C Partl, D Kalkofen, M Streit, S Gratzl, AM Wassermann, ...
IEEE transactions on visualization and computer graphics 19 (12), 2536-2545, 2013
462013
Systematic analysis of public domain compound potency data identifies selective molecular scaffolds across druggable target families
Y Hu, AM Wassermann, E Lounkine, J Bajorath
Journal of medicinal chemistry 53 (2), 752-758, 2010
432010
Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs
AM Wassermann, J Bajorath
Future Medicinal Chemistry 3 (4), 425-436, 2011
392011
Public domain HTS fingerprints: design and evaluation of compound bioactivity profiles from PubChem’s bioassay repository
KY Helal, M Maciejewski, E Gregori-Puigjane, M Glick, AM Wassermann
Journal of chemical information and modeling 56 (2), 390-398, 2016
322016
Comprehensive analysis of single‐and multi‐target activity cliffs formed by currently available bioactive compounds
AM Wassermann, D Dimova, J Bajorath
Chemical biology & drug design 78 (2), 224-228, 2011
322011
A screening pattern recognition method finds new and divergent targets for drugs and natural products
AM Wassermann, E Lounkine, L Urban, S Whitebread, S Chen, K Hughes, ...
ACS chemical biology 9 (7), 1622-1631, 2014
312014
Pathfinder: Visual analysis of paths in graphs
C Partl, S Gratzl, M Streit, AM Wassermann, H Pfister, D Schmalstieg, ...
Computer Graphics Forum 35 (3), 71-80, 2016
292016
Composition and applications of focus libraries to phenotypic assays
AM Wassermann, LM Camargo, DS Auld
Frontiers in pharmacology 5, 164, 2014
292014
Computational Analysis of Multi‐target Structure–Activity Relationships to Derive Preference Orders for Chemical Modifications toward Target Selectivity
AM Wassermann, L Peltason, J Bajorath
ChemMedChem 5 (6), 847-858, 2010
282010
The system can't perform the operation now. Try again later.
Articles 1–20